DPR Commission III: Indications Of Alleged Corruption At BPSDM Kemenkumham Must Be Proved

Member of Commission III DPR RI Arteria Dahlan/Antara

JAKARTA - Commission III of the DPR responded to the Indonesian Club's findings regarding the alleged corruption in the COVID-19 budget at the Human Resources Development Agency (BPSDM) of the Ministry of Law and Human Rights (Kemenkumham) worth Rp. 5.64 billion.

Member of Commission III of the DPR, Arteria Dahlan asked those who found indications of corruption within the Ministry of Law and Human Rights to prove their findings.

"Even if there are indications or allegations, I think it must be proven (Indonesia Club). Don't let this create a new commotion or polemic," said Arteria in Jakarta, Monday, January 17. The PDIP politician then questioned who made the specifications. According to him, there needs to be a test result that states that the drug does not meet specifications.

"First, who determines (BPOM specifications) who, right there must be a party with the capacity there. Second, under what conditions," said Arteria. Therefore, Arteria asked for proof of the findings and Commission III will follow up as a supervisory function. "This kind of thing must be tested. In principle, if there is an indication, we ask the party who postulated it to prove it. Of course, we in Commission III do our supervisory work,” he said. Even so, Arteria admitted that he had not received that information. He hoped the news was not true.

"We at Commission III hope that the news is not true. Because at the Ministry of Law and Human Rights itself, there are currently relatively many improvements. So that the ministry's governance, both technical and administrative, is much better," said Arteria. Previously, the Executive Director of the Indonesian Club, Gigih Guntoro, revealed that there were allegations of corruption in the COVID-19 Handling Fund, including the Procurement of Counterfeit Drugs and Multivitamins. The allegation arose because the drugs and multivitamins did not meet the BPOM specifications. The program period intended for these employees runs from April to June 2021 with a value of Rp. 5,644,450,000. Indications of counterfeiting of drugs and multivitamins occur because there is no conformity with the BPOM code, type of label, no expiration date, brand and form of packaging. This practice is clearly not only detrimental to the health of employees but also to the state's finances," he said in a written statement.